Alteration of the lysophosphatidic acid and its precursor lysophosphatidylcholine levels in spinal cord stenosis: A study using a rat cauda equina compression model.
Animals
Cauda Equina
/ pathology
Constriction, Pathologic
Disease Models, Animal
Female
Gene Expression Regulation
Lysophosphatidylcholines
/ blood
Lysophospholipids
/ blood
Neuralgia
/ metabolism
RNA, Messenger
/ genetics
Rats, Sprague-Dawley
Receptors, Lysophosphatidic Acid
/ genetics
Spinal Cord
/ pathology
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
12 11 2019
12 11 2019
Historique:
received:
14
05
2019
accepted:
22
10
2019
entrez:
14
11
2019
pubmed:
14
11
2019
medline:
30
10
2020
Statut:
epublish
Résumé
Cauda equina compression (CEC) is a major cause of neurogenic claudication and progresses to neuropathic pain (NP). A lipid mediator, lysophosphatidic acid (LPA), is known to induce NP via the LPA
Identifiants
pubmed: 31719574
doi: 10.1038/s41598-019-52999-5
pii: 10.1038/s41598-019-52999-5
pmc: PMC6851136
doi:
Substances chimiques
Lysophosphatidylcholines
0
Lysophospholipids
0
RNA, Messenger
0
Receptors, Lysophosphatidic Acid
0
lysophosphatidic acid
PG6M3969SG
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
16578Références
Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):463-70
pubmed: 25425621
Biochim Biophys Acta. 2013 Jan;1831(1):20-32
pubmed: 22884303
Neurol Med Chir (Tokyo). 2010;50(12):1070-3
pubmed: 21206180
Mol Cell Neurosci. 2000 Feb;15(2):170-82
pubmed: 10673325
Mol Pain. 2008 Apr 01;4:11
pubmed: 18377664
Prog Neurobiol. 2007 Jul;82(4):163-201
pubmed: 17643733
Nat Rev Neurol. 2009 Jul;5(7):392-403
pubmed: 19578346
Pain. 2010 Sep;150(3):439-50
pubmed: 20627413
Trends Pharmacol Sci. 2005 Nov;26(11):571-7
pubmed: 16185776
Antioxid Redox Signal. 2010 Oct;13(8):1157-67
pubmed: 20486758
Nat Chem Biol. 2011 Nov 20;8(1):78-85
pubmed: 22101604
Eur J Pain. 2007 May;11(4):370-6
pubmed: 16624601
Pain Res Manag. 2016;2016:5079675
pubmed: 27445615
Eur Spine J. 2007 Nov;16(11):1913-8
pubmed: 17992557
J Neuroinflammation. 2015 May 15;12:94
pubmed: 25971887
Biochim Biophys Acta. 2008 Sep;1781(9):513-8
pubmed: 18621144
Biol Pharm Bull. 2011;34(8):1154-8
pubmed: 21804198
Handb Clin Neurol. 2012;109:485-502
pubmed: 23098732
Curr Pain Headache Rep. 2019 Mar 19;23(5):32
pubmed: 30888546
J Neurosci Methods. 2010 Mar 15;187(1):8-12
pubmed: 20005255
J Bone Joint Surg Am. 2006 Apr;88 Suppl 2:21-4
pubmed: 16595438
Pain. 2017 Apr;158 Suppl 1:S55-S65
pubmed: 28151833
Prog Lipid Res. 2007 Mar;46(2):145-60
pubmed: 17459484
Trends Neurosci. 2005 Feb;28(2):101-7
pubmed: 15667933
Spine (Phila Pa 1976). 2007 Apr 20;32(9):939-42
pubmed: 17450066
Br J Anaesth. 2008 Jul;101(1):48-58
pubmed: 18511441
Anal Chem. 2019 Jul 16;91(14):8979-8986
pubmed: 31251568
Anal Biochem. 2007 Aug 1;367(1):20-7
pubmed: 17568554
Pain. 2008 Jul 31;137(3):473-7
pubmed: 18583048
Nat Rev Cancer. 2003 Aug;3(8):582-91
pubmed: 12894246
Sci Rep. 2019 Jun 24;9(1):9144
pubmed: 31235770
Curr Neuropharmacol. 2013 Dec;11(6):560-91
pubmed: 24396334
J Neurochem. 2011 Jul;118(2):256-65
pubmed: 21542849
J Neurosci. 2015 Jul 15;35(28):10224-35
pubmed: 26180199
Spine (Phila Pa 1976). 2003 Mar 15;28(6):616-20
pubmed: 12642771
Global Spine J. 2016 Mar;6(2):139-46
pubmed: 26933615
PLoS One. 2018 Nov 8;13(11):e0207310
pubmed: 30408112
J Cell Biochem. 2004 Aug 1;92(5):967-92
pubmed: 15258919
Pharmacol Ther. 2006 Jan;109(1-2):57-77
pubmed: 16023729
J Cell Biol. 2002 Jul 22;158(2):227-33
pubmed: 12119361